ClinicalTrials.Veeva

Menu

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

M

Menoufia University

Status

Not yet enrolling

Conditions

Total Dose of Bupivacaine Administered During Labor

Treatments

Drug: Dexmedetomidine 0.6 added
Device: Epidural Catheter with bupivacaine
Device: Epidural with dural puncture
Drug: Dexmedetomidine 0.4 added

Study type

Interventional

Funder types

Other

Identifiers

NCT07506044
2/2026ANET2-1

Details and patient eligibility

About

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Full description

The primary efficacy point is the total dose of bupivacaine administered during labor. The secondary endpoints include the VAS pain scores, number of administered additional doses, incidence of motor block, delivery type (spontaneous vaginal or cesarean), maternal satisfaction, and complications such as hypotension, fetal bradycardia, and epidural-related maternal fever.

Enrollment

140 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm,
  • normally presented singleton fetus, intact fetal membranes, and who are free of exclusion criteria

Exclusion criteria

Abnormal fetal presentation or lie, 'premature rupture of membranes, maternal fever, fetal distress, pregnancy-induced diseases

  • abnormal placental position,
  • ASA grade>II
  • marked obesity,
  • allergy or contraindications to the used drugs,
  • spinal deformity or disorders 'cutaneous diseases or infection at the injection site

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

140 participants in 4 patient groups

Epidural group with bupivacaine CE
Active Comparator group
Description:
Epidural with plain bupivacaine DPE
Treatment:
Device: Epidural Catheter with bupivacaine
Epidural puncture with bupivacaine
Active Comparator group
Description:
Combined epidural with epidural puncture using bupivacaine
Treatment:
Device: Epidural with dural puncture
Device: Epidural Catheter with bupivacaine
Epidural puncture with dexmedetomidine 0.4 (Bup/DEX0.6 )
Active Comparator group
Description:
Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.4
Treatment:
Drug: Dexmedetomidine 0.4 added
Device: Epidural with dural puncture
Device: Epidural Catheter with bupivacaine
Epidural puncture with dexmedetomidine 0.6 (Bup/DEX0.6 )
Active Comparator group
Description:
Combined epidural with epidural puncture using bupivacaine plus dexmetomedine0.6
Treatment:
Device: Epidural with dural puncture
Device: Epidural Catheter with bupivacaine
Drug: Dexmedetomidine 0.6 added

Trial contacts and locations

1

Loading...

Central trial contact

Rabab Habeeb, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems